Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy from a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR)
Authors:
Open Access
- 1 May 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 205 (5) , 1421-1429